The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 701–800 of 1,000
Jiang, W., Wang, Q., Liao, Y.-J., Peng, P., Xu, M., & Yin, L. (2017) · BMC Anesthesiology · doi:10.1186/s12871-017-0410-7 · Cited by 26
Ritchie, L., Tate, R. J., Chamberlain, L. H., Robertson, G., Zagnoni, M., Sposito, T., Wray, S., Wright, J. A., Bryant, C. E., Gay, N. J., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.025 · Cited by 26
“TLRs have been proposed to play a role in CNS diseases including Alzheimer's disease, Parkinson's disease and multiple sclerosis (Lucas et al., 2006) implicating TLRs as therapeutic targets in these diseases (Gambuzza et al.”
Causes and Consequences of MicroRNA Dysregulation Following Cerebral Ischemia-Reperfusion Injury
Forouzanfar, F., Shojapour, M., Asgharzade, S., & Amini, E. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190204104629 · Cited by 26
Bacterial lipopolysaccharide induces type 2 deiodinase in cultured rat astrocytes
Lamirand, A., Ramauge, M., Pierre, M., & Courtin, F. (2011) · Journal of Endocrinology · doi:10.1677/joe-10-0218 · Cited by 24
“These brain injuries are associated with acute inflammation (Lucas et al. 2006).”
BackgroundDisrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders
Marco, E. M., Velarde, E., Llorente, R., & Laviola, G. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_419 · Cited by 27
Pedersen, M. Ø., Larsen, A., Pedersen, D. S., Stoltenberg, M., & Penkowa, M. (2009) · PubMed · doi:10.14670/hh-24.573 · Cited by 26
“Extensive research results show that microglia-derived inflammatory mediators (including cytokines, ROS and complement) contribute to both acute and chronic tissue damage following TBI (for a review see Lucas et al., 2006).”
BackgroundCOVID-19: A Systematic Review of The Mechanisms of Injury to The Central Nervous System This Far
Loeb, L., & Mei, P. A. (2020) · InterAmerican Journal of Medicine and Health · doi:10.31005/iajmh.v3i0.115 · Cited by 25
Viñas-Ríos, J. M., Sánchez-Aguilar, M., Sánchez-Rodríguez, J. J., González-Aguirre, D., Heinen, C., Meyer, F., & Kretschmer, T. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000272 · Cited by 25
Pradhan, S. H., Gibb, M., Kramer, A. T., & Sayes, C. M. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116267 · Cited by 25
Martos, D., Lőrinczi, B., Szatmári, I., Vécsei, L., & Tanaka, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063394 · Cited by 25
Neuroinflammation Induced by Intracerebroventricular Injection of Microbial Neuraminidase
Granados‐Durán, P., López-Ávalos, M. D., Grondona, J. M., Gómez-Roldán, M. D. C., Cifuentes, M., Pérez‐Martín, M., Álvarez, M., de Fonseca, F. R., & Fernández‐Llebrez, P. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00014 · Cited by 25
“In any case, the clinical relevance of brain inflammation lies in part on the detrimental or even lethal effects of the invading defensive cells or proteins, which eventually can give rise to chronic neurodegenerative diseases (6, 7).”
BackgroundRoles of activated astrocytes in bone marrow stromal cell proliferation and differentiation
Wang, F.-W., Jia, D., Du, Z., Fu, J., Zhao, S., Liu, S.-M., Zhang, Y.-M., Ling, E., & Hao, A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.068 · Cited by 25
Morisugi, T., Tanaka, Y., Kawakami, T., & Kirita, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvp210 · Cited by 25
Antioxidative effect of phycoerythrin derived from Grateloupia filicina on rat primary astrocytes
Jung, S.-M., Park, J. S., Shim, H. J., Kwon, Y. S., Kim, H. G., & Shin, H. S. (2016) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-016-0369-0 · Cited by 26
“When CNS injury occurs, astrocytes are activated and help defend against subsequent harmful effects, even though severe reactive astrocytes form glial scars and interrupt regeneration or reorganization of the nerve system [14-17].”
BackgroundChen, Y., Ma, Y., Lin, C.-H., Cheng, S., Hsu, W., & Lee, E. H. Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00217 · Cited by 25
“…factoralpha (TNFα) are expressed in microglia cells and astrocytes in the brain, and their expression level is increased upon inflammation and brain damage (Lucas et al., 2006; Woodcock and Morganti-Kossmann, 2013); therefore, we determined IL-6 and TNFα levels in the CA1 area of these animals.”
BackgroundYe, Y., Yang, Y., Chen, C., Li, Z., Jia, Y., Su, X., Wang, C., & He, X. (2017) · Stem Cells International · doi:10.1155/2017/5841814 · Cited by 25
“As one of the leading life-threatening diseases worldwide, traumatic brain injury (TBI) often causes high mortality or a range of severe neurological deficits and long-term disability due to an inadequate self-repair capacity of the central nervous system (CNS) [1].”
BackgroundInfluentialKang, M., Ham, Y., Heo, S., Yoon, S., Cho, S.-H., Kwon, S., Jeong, M. S., Jeon, Y., Sanjeewa, K., Yoon, W., et al. (2018) · EXCLI journal · doi:10.17179/excli2018-1422 · Cited by 25
“However, an excessive inflammatory response can lead to various harmful effects in the human body, including cancer, cardiovascular disease, arthritis, and infec- tious disease (Lucas et al., 2006).”
BackgroundMerbl, Y., Sommer, A., Chai, O., Aroch, I., Zimmerman, G., Friedman, A., Soreq, H., & Shamir, M. H. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12462 · Cited by 25
Quiniou, C., Kooli, E., Joyal, J., Sapieha, P. S., Sennlaub, F., Lahaie, I., Shao, Z., Hou, X., Hardy, P., Lubell, W. D., et al. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.07.001 · Cited by 25
Hoshi, Y., Uchida, Y., Tachikawa, M., Ohtsuki, S., & Terasaki, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13960 · Cited by 25
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
Tesfaye, B. A., Hailu, H. G., Zewdie, K. A., Ayza, M. A., & Berhe, D. F. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s277720 · Cited by 24
Lee, H., Jang, J.-H., & Kim, S. (2021) · Animal Cells and Systems · doi:10.1080/19768354.2021.1901781 · Cited by 24
“Activated microglia cause neuroinflammation related to neurodegenerative disorders, thus, there is a possibility that they play a role in the development of Alzheimer’s disease (AD) and Parkinson’s disease (PD), among others (Olson and Miller 2004; Lucas et al. 2006; Hansen et al. 2018; Ho 2019).”
BackgroundMukty, S. A., Hasan, R., Bhuia, M. S., Saha, A. K., Rahman, U. S., Khatun, M. M., Bithi, S. A., Ansari, S. A., Ansari, I. A., & Islam, M. T. (2024) · Drug Development Research · doi:10.1002/ddr.22250 · Cited by 24
“Drugs that have an effect on the CNS are often used in the treatment of different neurological illnesses and conditions (Lucas et al., 2006).”
Crosstalk Between Insulin and Toll-like Receptor Signaling Pathways in the Central Nervous system
Hemmati, F., Ghasemi, R., Ibrahim, N. M., Dargahi, L., Mohamed, Z., Raymond, A. A., & Ahmadiani, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8631-3 · Cited by 24
“In spite of this delayed recruitment of leucocytes in the brain, microglial activation and release of inflammatory mediators are shown to be rapid (reviewed in [1]).”
InfluentialRegulation of glial inflammatory mediators synthesis: Possible role of endothelins
Filipovich‐Rimon, T., & Fleisher‐Berkovich, S. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.002 · Cited by 24
Rosa, L., Scaini, G., Furlanetto, C. B., Galant, L. S., Vuolo, F. S., Dall’Igna, D. M., Schuck, P. F., Ferreira, G. C., Dal‐Pizzol, F., & STRECK, E. L. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.11.002 · Cited by 24
“…now extensive evidence that neuroinflammation contributes to many acute and chronic degenerative disorders and, perhaps, some psychiatric diseases (Lucas et al., 2006), and it is also possible that the cytokines profiles by BCAA described here could contribute to the cognitive impairment that is…”
BackgroundVita, T. D., Albani, C., Realini, N., Migliore, M., Basit, A., Ottonello, G., & Cavalli, A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00556 · Cited by 24
Catale, C., Bisicchia, E., Carola, V., & Viscomi, M. T. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.032 · Cited by 24
Kwon, W. Y., Jung, Y. S., Suh, G. J., Kim, T.-K., Kwak, H., Kim, T., Kim, J. Y., Lee, M. S., Kim, K. S., Shin, J., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.07.026 · Cited by 24
Huang, D., Cao, Y., Zu, T., & Ju, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a0421-190r · Cited by 24
Cottrell, J. E., & Hartung, J. (2012) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.21283 · Cited by 24
Wu, X., Yang, S., Duan, D., Cheng, H., Bao, Y., & Zhang, Y. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0228 · Cited by 24
“We evaluated multiple endpoints, including (1) serum glucose and osmo-larity, (2) the Tarlov score and angles in the inclined plane, (3) amplitude and latency of motor-evoked potentials (MEPs), (4) apoptosis (TUNEL staining), (5) B-cell lymphoma/leukemia-2 gene (Bcl-2) and Caspase-3 expression (6) inducible nitric oxi…”
InfluentialIyirhiaro, G. O., Brust, T., Rashidian, J., Galehdar, Z., Osman, A., Phillips, M., Slack, R. S., MacVicar, B. A., & Park, D. S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05166.x · Cited by 24
Recent advances in neuroprotection for treating traumatic brain injury
Černak, I. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.11.1371 · Cited by 24
“This complex process includes intricate interactions between cytokines/chemokines, metalloproteases, NO and the arachidonic acid cascade among others [95,96].”
BackgroundZhao, G.-W., Wang, Y., Li, Y., Jiang, Z., Sun, L., Xi, X., He, P., Wang, G., Xu, S.-H., Ma, D.-M., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.041 · Cited by 23
Kuhn, T. B. (2014) · BioMed Research International · doi:10.1155/2014/191767 · Cited by 23
“Inflammatory and oxidative stress is a hallmark of neurodegeneration in most chronic, acute, and even some psychiatric CNS pathologies [3, 60, 61].”
BackgroundOntogeny of inter-alpha inhibitor proteins in ovine brain and somatic tissues
Spasova, M. S., Sadowska, G. B., Threlkeld, S. W., Lim, Y., & Stonestreet, B. S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213519195 · Cited by 23
“There is now evidence to suggest that bidirectional communications between the CNS and periphery could contribute to acute and chronic CNS disorders.(83) Increased levels of IAIPs in ovine plasma and CNS tissue during development could be related to the importance of these molecules in systemic and CNS inflammatory an…”
BackgroundTeixeira, P. G., Karamanos, E., Okoye, O. T., Talving, P., Inaba, K., Lam, L., & Δημητριάδης, Δ. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31829bb976 · Cited by 23
Manuel, V.-R., Sánchez-Aguilar, M., Juan, S.-R. J., Fernando, M.-A., Frerk, M., Kretschmer, T., & Heinen, C. (2015) · Asian Journal of Neurosurgery · doi:10.4103/1793-5482.161171 · Cited by 23
“One cause might be the loss of cerebrovascular autoregulation, as a consequence of hypoxia and neuroinflammation.([15,17]) Different study groups discovered that TBI combined with hypoxia enhances cerebral cytokine production.”
BackgroundWilson, J. R. F., Saeed, F., Tyagi, A., Goodden, J. R., Sivakumar, G., Crimmins, D. W., Elliott, M., Picton, S., & Chumas, P. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-017-3388-5 · Cited by 23
“This is unusual, as the brain is traditionally considered an immuneprivileged site and central nervous system inflammation/ infection can often manifest with little systemically measurable response [10].”
BackgroundNovel targets for Spinal Cord Injury related neuropathic pain
Ahmed, M. M., King, K. C., Pearce, S. M., Ramsey, M. A., Miranpuri, G. S., & Resnick, D. K. (2011) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.1118413 · Cited by 23
Cohen, M. E., Fainstein, N., Lavon, I., & Ben‐Hur, T. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.06.001 · Cited by 23
Lee, M. C., Rakwal, R., Shibato, J., Inoue, K., Chang, H., & Soya, H. (2014) · Physiological Reports · doi:10.14814/phy2.12206 · Cited by 23
“higher levels of inflammatory cytokines are reported in the aged brain (Godbout and Johnson 2006) and neurodegenerative disorders such as Alzheimer’s disease and other chronic conditions (Lucas et al. 2006).”
BackgroundFeng, Z., Pearce, L. V., Zhang, Y., Xing, C., Herold, B. K. A., Ma, S., Hu, Z., Turcios, N. A., Yang, P., Tong, Q., et al. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9888-z · Cited by 23
Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain
Wolfberg, A., Dammann, O., & Gressèns, P. (2007) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2007.01.021 · Cited by 23
Gong, P., Liu, Y., Huang, T., Chen, W., Jiang, T., Gong, Y., Lü, M., Wang, M., Zhang, Y., Zhang, X., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1538-5 · Cited by 22
Rowe, R. K., & Griesbach, G. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.04.017 · Cited by 22
Wang, T., Pan, C.-L., Xie, C., Chen, L., Song, Z., Liao, H.-L., & Xin, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03473-x · Cited by 23
“During ischemic brain injury, inflammatory cells have vital roles, e.g., microglia, which are resident macrophages and are differentiated from peripheral blood monocytes, are represented by different M1 and M2 phenotypes [48].”
BackgroundMechanistic insight of curcumin: a potential pharmacological candidate for epilepsy
Khatoon, S., & Kalam, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1531288 · Cited by 22
Lessons from genome‐wide association studies findings in Alzheimer's disease
Moraes, C. F., Lins, T. C. D. L., CARMARGOS, E. F., Naves, J. O. S., Pereira, R. W., & Nóbrega, O. D. T. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00378.x · Cited by 22
Brain Aging and Regeneration after Injuries: an Organismal approach.
Buga, A.-M., Vintilescu, R., Pop, O. T., & Popa‐Wagner, A. (2011) · Europe PMC (PubMed Central) · Cited by 22
“Neuropeptides in the brain defense against distant organ damage”
Hamasaki, M. Y., Barbeiro, H. V., Barbeiro, D. F., Cunha, D. M. G., Koike, M. K., Machado, M. C. C., & da Silva, F. P. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.014 · Cited by 22
“It is now appreciated, however, that the central nervous system exhibits clear features of immune activation in response to distant infectious processes (Lucas et al., 2006).”
Wang, M., Zhi, D., Wang, H., Ru, Y., Ren, H. J., Wang, N., Liu, Y., Li, Y., & Li, H. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7251-4 · Cited by 22
Wang, Y., Wei, Y., Oguntayo, S., Wilder, D. M., Tong, L. C., Su, Y., Gist, I. D., Arun, P., & Long, J. B. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4465 · Cited by 22
Kaur, S., Kumari, P., Singh, G., Bhatti, R., & Singh, P. (2018) · ACS Omega · doi:10.1021/acsomega.8b00445 · Cited by 22
The role of immune and glial cells in neurodegenerative processes
Abdurasulova, I. N., & Клименко, В. М. (2011) · Medical academic journal · doi:10.17816/maj11112-29 · Cited by 22
Melanocortins in Brain Inflammation: The Role of Melanocortin Receptor Subtypes
Muceniece, R., & Dambrova, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6354-3_5 · Cited by 23
Estrogen, the Peripheral Immune System and Major Depression – A Reproductive Lifespan Perspective
Engler-Chiurazzi, E. B., Chastain, W. H., Citron, K. K., Lambert, L. E., Kikkeri, D. N., & Shrestha, S. S. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.850623 · Cited by 22
Hauss, F., Liu, J., Michelucci, A., Coowar, D., Morga, E., Heuschling, P., & Luu, B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.037 · Cited by 22
Patro, N., Singh, K., & Patro, I. K. (2013) · PubMed · Cited by 22
Krieg, S. M., Voigt, F., Knuefermann, P., Kirschning, C. J., Plesnila, N., & Ringel, F. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00455 · Cited by 22
“Moreover, NO is produced by glial iNOS of which is known to be induced not only by IL-1β but also by IFN-α and TNF (6).”
BackgroundIron Pathophysiology in Stroke
Almutairi, M. M., Xu, G., & Shi, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_6 · Cited by 22
Trincavelli, M. L., Tonazzini, I., Montali, M., Abbracchio, M. P., & Martini, C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21611 · Cited by 22
“In response to injuries, resident CNS cells generate proinflammatory cytokines, which may contribute to acute and chronic brain disease pathogenesis through the recruitment of immune cells and the activation of glial cells [for review see Lucas et al., 2006].”
BackgroundYarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Plasma GDF15 level is elevated in psychosis and inversely correlated with severity
Kumar, P., Millischer, V., Villaescusa, J. C., Nilsson, I. A. K., Östenson, C., Schalling, M., Ösby, U., & Lavebratt, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07503-2 · Cited by 21
Schuhmann, M. K., Stoll, G., Bohr, A., Volkmann, J., & Fluri, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092341 · Cited by 21
“The leukocytes enter the ischemic brain area from cerebral blood vessels via the compromised blood–brain barrier [41].”
BackgroundZhang, W., Zhou, X., Yin, J., Zhao, W., Huang, C., Zhang, C., Wan, K., Li, M., Zhu, X., & Sun, Z. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148318 · Cited by 21
Abbasloo, E., Amiresmaili, S., Shirazpour, S., Khaksari, M., Kobeissy, F. H., & Thomas, T. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-31891-3 · Cited by 21
Singh, A., Verma, A., Bhardwaj, B., Saraf, P., Kumar, H., Jain, N., Waiker, D. K., Gajendra, T. A., Krishnamurthy, S., & Shrivastava, S. K. (2024) · ACS Omega · doi:10.1021/acsomega.3c10276 · Cited by 21
López-Villodres, J. A., Cruz, J. P. D. L., Muñoz-Marín, J., Guerrero, A., Reyes, J. J., & Correa, J. A. G. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.01.001 · Cited by 21
“In this connection, components of oxidative or nitrosative stress were shown to participate in the neuroinflammatory process and prostaglandin synthesis (Lucas et al., 2006; Munhoz et al., 2008).”
BackgroundAnti-inflammatory constituents fromPerovskia atriplicifolia
Ahmad, I., Waheed, A., Tahir, N. B., & Rais, A. K. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.997250 · Cited by 21
“Inflammation is a major component of the damage caused by autoimmune diseases and is also a fundamental contributor to diseases such as cancer, diabetes, and cardiovascular disease (Lucas et al., 2006).”
BackgroundEsculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-γ
Li-hua, D., Li, Y., Shi-ji, W., Guang, W., Lu-lu, S., Xue-feng, P., & Pengda, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.029 · Cited by 21
“Introduction A large body of studies showed that inflammation is a major pathological cause for neurodegenerative diseases, such as Parkinson disease (PD) and Alzheimer’s disease (Kim and Joh, 2006; Lucas et al., 2006).”
BackgroundLorente, L., Martin, M. M. I. D. O., Abreu-González, P., Pérez-Cejas, A., Ramos, L., Argüeso, M., Solé‐Violán, J., Cáceres, J. J., Jiménez, A., & García‐Marín, V. (2018) · Journal of International Medical Research · doi:10.1177/0300060518775008 · Cited by 21
Dar, M. A., Bhat, M. F., Mir, R. H., Masoodi, M. H., Mir, S. R., & Mohi-ud-din, R. (2018) · The Natural Products Journal · doi:10.2174/2210315508666180821153531 · Cited by 21
Delineating Astrocytic Cytokine Responses in a Human Stem Cell Model of Neural Trauma
Thelin, E. P., Hall, C. E., Tyzack, G. E., Frostell, A., Giorgi-Coll, S., Alam, A., Carpenter, K. L. H., Mitchell, J. S., Tajsic, T., Hutchinson, P. J., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6480 · Cited by 21
“Although microglia have been described as the primary mediator of inflammation in the CNS,(12) there is a growing interest in the immunocompetence of other cells in the CNS.(13) Astrocytes, which are supportive glial cells, are increasingly recognized to possess”
Vahdat, M., Hosseini, S. A., Soltani, F., Cheraghian, B., & Namjoonia, M. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00712-6 · Cited by 21
“TBI is associated with increased levels of cytokines such as IL-6, IL-10, and TNFα [11–13], which worsen the TBI condition and delay the improvement by generating oxidative stress and metalloproteinases [14, 15].”
BackgroundRegulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes
Piątkowska‐Chmiel, I., Herbet, M., Gawrońska‐Grzywacz, M., & Dudka, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105502 · Cited by 21
“IL-1β (A), IL-6 (B), and TNFα (C) were measured by ELISA kits in the serum of blood; IL-1β (D), IL-6 (E), and TNFα (F) were measured by ELISA kits in the prefrontal cortex.”
BackgroundInfluentialTzeng, Y., Lee, Y., Cheng, W.-T., Shih, H.-N., Wang, H.-C., Rao, Y. K., & Lee, M. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.004 · Cited by 21
Wang, J., Chen, S., Zhang, X., Huang, W., & Jonas, J. B. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12698 · Cited by 21
“Although moderate inflammatory stimulation can transform RGCs into a regenerative state and may be beneficial for regrowing axons into the damaged optic nerve, a high concentration of inflammatory cytokines can lead to secondary nerve damage (Lucas et al. 2006; Sun et al. 2011).”
BackgroundAhras-Sifi, N., Martin‐Eauclaire, M., & Laraba‐Djebari, F. (2016) · Inflammation Research · doi:10.1007/s00011-016-0945-y · Cited by 21
“channels lead to various forms of epilepsy, ion channel dysfunction could be the main cause of seizures and neurodegenerative processes; however, the pathogenic mechanisms involved in epilepsy are still poorly understood [5, 6].”
BackgroundThomale, U. W., Bender, M., Casalis, P. A., Rupprecht, S., Griebenow, M., Neumann, K., Woiciechowsky, C., Unterberg, A. W., & Stover, J. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.01.007 · Cited by 21
“Over time, the influence of various cytokines with reparative potential involved in regeneration and recovery processes prevails (Lucas et al., 2006).”
BackgroundHuang, C., Wen, Y., Desai, T. D., & Tsai, R. (2021) · Antioxidants · doi:10.3390/antiox10121934 · Cited by 20
Mahmoudi, N. E., Marouane, E., Rastoldo, G., Péricat, D., Watabe, I., Lapôtre, A., Tonetto, A., Chabbert, C., & Tighilet, B. (2022) · Cells · doi:10.3390/cells11172693 · Cited by 20
Álvarez, S., Blanco, A., Fresno, M., & Muñoz‐Fernández, M. Á. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06646.x · Cited by 20
Zhang, Z. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.719 · Cited by 20
Nassar, A., Sharon-Granit, Y., & Azab, A. N. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.019 · Cited by 20
Association between obesity-related biomarkers and cognitive and motor development in infants
Camargos, A. C. R., Mendonça, V. A., Oliveira, K. S. C., de Andrade, C. A., Leite, H. R., da Fonseca, S. F., Vieira, É. L. M., Teixeira, A. L., & Lacerda, A. C. R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.030 · Cited by 20
Possible role of miR-204 in optic nerve injury through the regulation of GAP-43
Wang, N., Yang, W., Xiao, T., Miao, Z., Luo, W., You, Z., & Li, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8341 · Cited by 20
“The results showed that the levels of TLR4, MyD88 and NF-κ B increased significantly in the optic nerve injury group, and treatment with miR-204 inhibitor following optic nerve injury decreased the levels of TLR4, MyD88 and NF-κ B, which was consistent with the result of a previous study (13).”
Du, L., Sun, Y., Wang, Q., Wang, L., Zhang, Y., Li, S., Jin, H., Yan, S., & Xiao, X. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110323 · Cited by 20
Defort, P., Retkowska-Tomaszewska, N., Kot, M., Jarmużek, P., Tylutka, A., & Zembroń-Łacny, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030705 · Cited by 20
“Alterations in blood–brain barrier permeability may contribute to secondary brain injury through an abnormal passage of blood-borne substances into the extravascular space, increasing neuronal vulnerability [9,10].”
BackgroundAyer, R. E., Jafarian, N., Chen, W., Applegate, R. L., Colohan, A. R. T., & Zhang, J. H. (2011) · Journal of neurosurgery · doi:10.3171/2011.8.jns11883 · Cited by 20
Do cytokines have any role in Wilson's disease?
Goyal, M. K., Sinha, S., Patil, S. A., Jayalekshmy, V., & Taly, A. B. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03755.x · Cited by 20
The role of N-glycosylation of CD200-CD200R1 interaction in classical microglial activation
Liu, C., Shen, Y., Tang, Y., & Gu, Y. (2018) · Journal of Inflammation · doi:10.1186/s12950-018-0205-8 · Cited by 20
Molecular targets for disrupting leukocyte trafficking during multiple sclerosis
McCandless, E. E., & Klein, R. S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000397 · Cited by 20
Role of GSK-3β in isoflurane-induced neuroinflammation and cognitive dysfunction in aged rats
Li, S., Chen, X., Chen, Y.-L., Tan, L., Zhao, Y., Wang, J.-T., Xiang, Q., & Luo, A. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1154-3 · Cited by 20
Banik, A., Amaradhi, R., Lee, D. D., Sau, M., Wang, W., Dingledine, R. J., & Ganesh, T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02297-7 · Cited by 19
“Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga.”
BackgroundInfluentialWang, G. H., Yan, Y., Shen, H. P., & Chu, Z. (2022) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2022.0078 · Cited by 19
“Traumatic deformation of the cell membrane (22), hyperphenylalanineemia (32), decreased serum magnesium concentration and hyperventilation to control the increased ICP (8) might all promote the entrance of calcium”
BackgroundShedding light on the etiology of neurodegenerative diseases and dementia: the exposome paradigm
Cavaliere, F., & Gülöksüz, S. (2022) · npj Mental Health Research · doi:10.1038/s44184-022-00018-3 · Cited by 19
Echinatin protects from ischemic brain injury by attenuating NLRP3-related neuroinflammation
Sun, L., Chen, D., Zhao, C., Hu, Y., Xu, Y., Xia, S., Yang, H., Bao, X., Zhang, Z., Zhou, C., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105676 · Cited by 19
Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases
Williams, W. M., Weinberg, A., & Smith, M. A. (2011) · Journal of Amino Acids · doi:10.4061/2011/461216 · Cited by 19
“This was demonstrated histochemically in AD brain, where activated microglial cells and astrocytes, both resident immune cells of the brain [45], express proinflammatory cytokines, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, along with ROS [46].”
Background
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.